A Changing Landscape for Obesity Treatment GLP-1 receptor agonists have transformed obesity and diabetes treatment in recent years, driving unprecedented demand and prompting rapid expansion of compounded alternatives during periods of limited supply and high cost
This effect makes it much easier to tackle obesity and reach a healthy weight
Nicholas Peiper For National Eating Disorders Awareness Week, were sharing what were learning from our ongoing studies in the EAT Lab about preventing and treating eating disorders
HFD has been shown to reduce NPY1R expression in the DMH in males but not in females (100, 101)
This review focuses on these advances in knowledge, including their implications for more personalised and effective management of diabetes
Enter Pepzyme AG Pepzyme AG is a powerful proteolytic enzyme blend expertly designed to support protein digestion, with a particular focus on complex substrates such as collagen